Biotech

Startups News

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech

Top news of the week: 05.01.2022.

Bristol-Myers Squibb
Biotechnology
Chemotherapy
Industry
Smallpox
Medical test

Startups

@MassBio shared
On Jan 4, 2022
Applications are now open for our 8-week hybrid accelerator program #MassBioDrive! Accelerate your early-stage biotech and advance breakthrough science with access to training, resources, & networks at no cost. Learn more & apply by 2/4: https://t.co/YgSwhxslhb
Open
Drive

Drive

MassBioDrive is a next generation accelerator designed to advance breakthrough science and provide opportunities to innovators from all parts of the life science ecosystem.

@sciam shared
On Dec 30, 2021
The recently approved "CORBEVAX is the first COVID vaccine designed specifically for global health. It is a milestone for global vaccine equity, something we believe will overcome vaccine hesitancy." | Analysis by @PeterHotez & @mebottazzi https://t.co/RCnXfM6Lql
Open
A COVID Vaccine for All

A COVID Vaccine for All

With proved technology and no-frills tech transfer, CORBEVAX is poised to reach hundreds of millions in the coming weeks

@BentheFidler shared
On Jan 3, 2022
10 clinical trials to watch in the first half of 2022 https://t.co/l2Ur8XYxrC $KRTX $ARNA $ALNY $ICPT $GILD $ABBV
Open
10 clinical trials to watch in the first half of 2022

10 clinical trials to watch in the first half of 2022

Biotech stocks ended 2021 in a slump. But positive results from eagerly anticipated studies in breast cancer, schizophrenia and Alzheimer's disease could help turn the sector's fortunes ...

@BentheFidler shared
On Jan 5, 2022
5 FDA approval decisions to watch in the first quarter https://t.co/E19tZjiVBu $LLY $AKBA $BMY $AZN $GILD $MRK
Open
5 FDA approval decisions to watch in the first quarter

5 FDA approval decisions to watch in the first quarter

The first three months of 2022 could bring clearances for a new type of immunotherapy and a first-of-its kind HIV drug as well as mark the start of a price battle in oncology.

@MassBio shared
On Jan 3, 2022
For our January #MemberSpotlight, we spoke with Rahul Singhvi from National Resilience. Read the full Spotlight to learn how Resilience is working to revolutionize how complex medicines are made following the #Covid19 Pandemic: https://t.co/fAAroaNcFM
Open
Member Spotlight: Q&A with National Resilience Inc.

Member Spotlight: Q&A with National Resilience Inc.

Every month, MassBio spotlights a member company and the great work they’re doing to advance the life sciences industry and support the patients we serve. In January, we spoke with Rahul ...

@Forbes shared
On Jan 3, 2022
2021 EV Sales Were Electrifying https://t.co/mjCuz0czCD https://t.co/K6p9Dm2nnq
Open
2021 EV Sales Were Electrifying

2021 EV Sales Were Electrifying

It was a quiet start to 2022 with markets closed in China, Japan, and Australia.

@WIRED shared
On Jan 4, 2022
After 7 days of deliberations, a jury in San Jose, California, found Elizabeth Holmes guilty on 4 counts of wire fraud & conspiracy to commit wire fraud. The jury returned a verdict of not guilty on another 4 counts, & could not come to a consensus on 3: https://t.co/PwrDnrUcDq
Open
Theranos Founder Elizabeth Holmes Is Convicted on 4 Counts

Theranos Founder Elizabeth Holmes Is Convicted on 4 Counts

A jury acquits the former CEO of the failed blood-testing startup on four other charges, and deadlocks on three.

@GENbio shared
On Jan 4, 2022
Elizabeth Holmes, CEO whose startup Theranos parlayed the promise of revolutionary diagnostics into a business valued at $9 billion, was convicted Monday on four of 11 federal charges that the company defrauded patients and investors. Read more: https://t.co/5MmUTsRIdM
Open
Theranos’ Elizabeth Holmes Convicted on Fraud, Conspiracy Charges

Theranos’ Elizabeth Holmes Convicted on Fraud, Conspiracy Charges

Elizabeth Holmes, the founder and CEO whose startup Theranos parlayed the promise of revolutionary diagnostics into a business valued at $9 billion, was convicted Monday on four of 11 ...

Read more: Startups
weekly 05.01.2022
View archives
Back to home

Subscribe to Biotech - Startups.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech - Startups.
Privacy Policy

Sign up for the weekly Biotech - Startups newsletter

Never again miss anything or anyone that matter in Biotech

Sign up and receive the Biotech - Startups weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy